Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Clinical trial NCT03353350 · COMPLETED
Trial details
- NCT number
- NCT03353350
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-05
- Primary completion
- 2020-01-29
- Enrollment
- 406
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.